NexGel elects Aviv Argaman to board
NXGL•NexGel elected Aviv Argaman as an independent director on November 12, 2026, effective immediately. On November 18, the board formed a committee including Argaman to evaluate and negotiate the proposed merger with Fountainhead LifeSciences and its affiliates.




